MedPath

Effect of Diclofenac 0.1% Vs. Nepafenac 0.1% on anterior chamber reaction in post-operative (cataract) cases.

Phase 4
Conditions
Anterior chamber reaction inside the eye after cataract surgery.
Cystoid macular edema following cataract surgery, unspecified eye
H59.039
Registration Number
IRCT20220607055097N2
Lead Sponsor
owshera Medical College/ Qazi Hussain Ahmad Medical Complex
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients’ = 50 yrs.
Both males and females
with visually significant senile-cataracts under-going phacoemulsification with intra-ocular lens implantation

Exclusion Criteria

Any past intra-ocular surgery
Any history of any intra-ocular inflammatory diseases,
Traumatic globe injuries
Corneal disorders impairing the view
Any glaucomatous diseases of eye
Pseudo-exfoliation cataracts
any retinal/macular abnormalities, such as macular edema due to other etiologies or epi-retinal membranes or any age-related maculopathy.
Those not willing to follow the study protocols and requirements of follow up
Those who were pre-diabetics and confirmed diabetics
Those with systemic autoimmune/inflammatory disorders or any history of allergic reaction to the study drugs or other NSAIDs
Patients with eventful phaco surgery such as posterior-capsular tear, vitreous-prolapse or post-operative fibrinous reactions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath